DR. SOFIE KERKAERT
Sources: the KBO register on 22-11-2026; the National Bank, 2025 annual accounts filed on 30-07-2026; the Belgian Official Gazette, latest deed of 06-10-2021.
Grounds
the facts the verdict rests on, each with its source- DR. SOFIE KERKAERT made a profit in every financial year since 2022.Annual accounts 2022 to 2025 page 2
- Equity stands at €312,993, or 83.8% of the balance sheet total of €373,499. The solvency of 83.8% is higher than at 75% of the 21,385 companies filing micro accounts in human health (NACE 86) in 2025.Annual accounts 2025 page 2
- Of the €60,506 of debt, €38,412 runs for more than a year.Annual accounts 2025, notes page 2
- The last four annual accounts came in on time. The 2025 accounts were filed 1 day before the end of the term.National Bank, filing of 30-07-2026 page 4
Representation
The signing rule is in the deed of 06-10-2021.
Articles of association, Belgian Official Gazette of 06-10-2021, deed 21358533
Ownership
The accounts in the micro format list no shareholders. founded DR. SOFIE KERKAERT by deed of 06-10-2021.
Deed of 06-10-2021
Financial situation
Annual accounts 2022 to 2025, as filed with the National Bank
Gross margin and net resultin euro
Equity and debtsin euro
Cashin euro
| Financial year | 202214 months | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|
| Results | |||||
| Gross margin | €140,018 | €105,389 | €115,931 | €125,834 | |
| Operating result | €120,735 | €89,605 | €93,893 | €104,163 | |
| Net result | €92,439 | €68,909 | €70,568 | €80,676 | |
| Balance sheet at the closing date | |||||
| Equity | €93,639 | €161,749 | €232,317 | €312,993 | |
| Debts | €79,943 | €90,648 | €97,001 | €60,506 | |
| Debts due after more than one year | €6,251 | €43,747 | €53,056 | €38,412 | |
| Debts due within one year | €73,080 | €45,534 | €43,945 | €22,095 | |
| Cash | €98,122 | €141,667 | €200,894 | €133,266 | |
| Balance sheet total | €173,582 | €252,397 | €329,318 | €373,499 | |
| Ratios | |||||
| Solvency | 53.9% | 64.1% | 70.5% | 83.8% | |
| Liquidity | 1.70 | 3.97 | 5.24 | 12.57 | |
Source: Annual accounts 2025, micro format, filed on 30-07-2026 (2026-00358965); Annual accounts 2024, micro format, filed on 31-07-2025 (2025-00350899); Annual accounts 2022 to 2023, filed from 19-07-2023 to 16-07-2024 (2023-00250224, 2024-00251031).
The operating result of 2025 is 11% higher than in 2024.
Debts fell by €36,495 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
DR. SOFIE KERKAERT states no turnover; the micro format does not require it. The gross margin, what is left after purchases, rose from €115,931 to €125,834.
Board, signature and ownership
Position on 22-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The signing rule is in the deed of 06-10-2021.
Articles of association, Belgian Official Gazette of 06-10-2021, deed 21358533
Board
two directors in officeOwnership and group
Shareholders
The accounts in the micro format list no shareholders. founded DR. SOFIE KERKAERT by deed of 06-10-2021.
Deed of 06-10-2021
Events and comparison
The last 24 months, newest first
Annual accounts 2025 filed, 1 day before the deadline.
NBB filingLiquidity more than doubled. The current ratio rises from 5.24 to 12.57. Short-term debt falls from €43,945 to €22,095.
FinancialAnnual accounts 2024 filed. On the deadline day.
NBB filingEquity above €200,000. With a profit in every financial year since 2022, equity grows to €232,317.
FinancialComparable companies, two years later
In July 2024, 26,977 companies had the same profile as DR. SOFIE KERKAERT has now: micro, 5 to 10 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 94.9% were still trading, 3.5% had stopped another way and 1.6% had gone bankrupt.
The return on assets of DR. SOFIE KERKAERT, 21.6%, is higher than at 53% of the 21,236 companies filing micro accounts in human health (NACE 86) in 2025.
Other findings
Peppol
Reachable for e-invoices, under 0208:0774993376.
Sanctions lists
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 22-11-2026 | KBO 0774.993.376 |
| National Bank of Belgium | Annual accounts 2025, micro format | 30-07-2026 | 2026-00358965 |
| National Bank of Belgium | Annual accounts 2024, micro format | 31-07-2025 | 2025-00350899 |
| National Bank of Belgium | Annual accounts 2022 to 2023 | 19-07-2023 to 16-07-2024 | 2023-00250224, 2024-00251031 |
| Belgian Official Gazette | Articles of association with the signing rule | 06-10-2021 | deed 21358533 |
| Peppol Directory | Registration for e-invoices | 0208:0774993376 | |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 19-11-2026 | |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 21-11-2026 | bankruptcy model of 21 November 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 21 November 2026, computed on 21-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.